Compare AbCellera Biologics Inc (ABCL) vs FTAI Aviation Ltd (FTAI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs FTAI Aviation Ltd — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while FTAI Aviation Ltd trades at $228.88 (market cap $23.17B). The key difference: FTAI Aviation Ltd is far larger — about 7.7× AbCellera Biologics Inc's market cap, and FTAI Aviation Ltd pays a 0.89% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | FTAI | |
|---|---|---|
Market Cap | $2.99B | $23.17B |
Sector | Health | Industrials |
52-Week High | $9.76 | $310.04 |
52-Week Low | $2.78 | $140.40 |
Enterprise Value | $2.58B | $26.29B |
Dividend Yield | — | 0.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) surged 34.78% to $9.34, driven by positive Phase 2 trial results for its menopause drug ABCL635. Despite negative net income margins and cash burn, analyst consensus is strongly bullish with a $15.50 price target. The stock shows a bullish technical trend, with support at $8 and resistance at $10, though RSI levels indicate overbought conditions.
The outlook hinges on ABCL635's clinical progress and future revenue potential, but high valuation ratios and persistent losses pose significant risks. Investor sentiment is optimistic due to recent drug trial success, yet the company must demonstrate a path to profitability to justify current market enthusiasm.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About FTAI Aviation Ltd
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →
